WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Marcio SouzaChief Executive Officer2024-02-12271$44.65
$12.10kSell
Lauren MastrocolaPrincipal Accounting Officer2024-02-1248$44.65
$2.14kSell
Alex NemiroffGeneral Counsel and Secretary2024-02-1251$44.65
$2.28kSell
Alex NemiroffGeneral Counsel and Secretary2024-01-0789$25.19
$2.24kSell
Timothy Edwin KellyChief Financial Officer2024-01-07139$25.19
$3.50kSell
Lauren MastrocolaPrincipal Accounting Officer2024-01-0735$25.19
$881.65Sell
Marcio SouzaChief Executive Officer2024-01-07418$25.19
$10.53kSell
Jill DesimoneDirector2023-10-0514,500$1.75
$25.38kBuy
Marcio SouzaChief Executive Officer2023-06-2710,000$1.06
$10.59kBuy
Alex NemiroffGeneral Counsel and Secretary2023-05-1211,686$0.88
$10.33kBuy

1 of 2

PRAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP36.97%4,894,109$228.02MInsider
Stefan Vitorovic22.20%2,939,329$136.94MInsider
Holdings A. Novo18.45%2,442,080$113.78MInsider
Clarus Lifesciences Iii LP6.85%907,378$42.27MInsider
Adage Capital Partners GP LLC5.58%738,666$34.41MInstitution
Verition Fund Management LLC5.31%703,000$32.75MInstitution
Point72 Asset Management LP5.23%692,252$32.25MInstitution
Pfm Health Sciences LP4.96%656,548$30.59MInstitution
Cormorant Asset Management LP4.78%633,345$29.51MInstitution
Kiran Reddy3.53%467,289$21.77MInsider

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX40.09%59.91%Net BuyingNet Selling
ORIC70.31%29.69%Net SellingNet Selling
ZYME61.32%38.68%Net Buying
AVTE66.43%33.57%Net SellingNet Selling
LBPH45.89%0.09%Net SellingNet Selling
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 60.55% institutional shareholders, 90.48% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 36.97% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $229.48M.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.